FDA Clearance Tracker · P980041
ACCESS AFP IMMUNOASSAY SYSTEM
Last checked: Nov 20, 2026Latest source record: Feb 8, 1999 (this decision)Source: openFDAMethods & limitations
Decided
Feb 8, 1999
Approved
Time to decision
115 days
Received Oct 16, 1998. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P980041
- Device name
- ACCESS AFP IMMUNOASSAY SYSTEM
- Applicant
- Beckman Coulter, Inc.
- Applicant location
- Brea, CA
- Received
- Oct 16, 1998
- Decided
- Feb 8, 1999
- Decision
- Approved
- Supplements
- 47 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
FDA's approval statement
As written in FDA's record.
Approval for the Access(R) AFP Reagents on the Access(R) Immunoassay Analyzer. The Access(R) AFP assay is a paramagnetic particle, chemiluminescent immunoassay for use with the Access(R) Immunoassay System for the quantitative determination fo alpha-fetoprotein (AFP) in: 1)Human seru, as an aid in management of patients with non-seminomatous testicular cancer. 2) Maternal serum and amniotic fluid at 15 to 20 weeks gestation, to aid in the detection of fetal open neural tube defects (ONTD). The assay is intended for use in conjunction with other diagnostic tools such as ultrasound and amniography.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LOK. The earliest in FDA's data is P820060, decided Jun 21, 1983.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Beckman Coulter, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Access BNP II510(k)
K262597 · Decided Oct 20, 2026 · 85 days after receipt
Device type: Test, Natriuretic Peptide (NBC) · Laboratory Medicine & Pathology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.